This concise practical guide is designed to facilitate the clinical decision-making process in the management of vitiligo by reviewing a selection of illustrative cases and defining the various diagnostic and management decisions open to clinicians. Vitiligo is an autoimmune skin condition and is the most common pigmentary disorder that affects 1% of the population worldwide. It is a debilitating and psychologically devastating skin disease with around 50% of patients developing it before the age of 20 years.

Professor Viktoria Eleftheriadou is a Consultant Dermatologist at Walsall Healthcare & The Royal Wolverhampton NHS Trust and Honorary Clinical Professor at the Institute for Global Health and Wellbeing, School of Medicine , Keele University. Her research interests include global dermatology, vitiligo and skin pigmentary disorders, evidence-based dermatology, trials methodology, outcome measures and qualitative research. She was awarded her PhD on vitiligo in 2013, which was conducted at the Centre of Evidence Based Dermatology, UoN and funded by the National Institute for Health Research. She is the lead author of recently updated national British Association of Dermatologists guidelines for the management of vitiligo 2021. Currently, she is working on several projects including observational study and international registry for vitiligo patients (VIRTUAL Global) and a clinical trial on the effectiveness of psychological interventions for the management of vitiligo. She has published over 100 peer reviewed articles and is a Section Editor for the British Journal of Dermatology, one of the top 3 Dermatology journals in the world. She is also the Co-Director for the Global Vitiligo Atlas (GLOVA) created under the auspices of the International League of Dermatological Societies (ILDS).

Khaled EZZEDINE MD, PhD, is a clinician and researcher working as a full Professor in Henri Mondor Hospital and the Université Paris Est Créteil, in Créteil, France. His main clinical interests are vitiligo pigmentation disorders, atopic dermatitis and alopecia areata. His research topics include qualitative epidemiology and construction of cohorts. He has authored more than 330 articles in peer-reviewed journals (H-Impact 54). He is the leader of the Skin groups of two French national cohorts, NUTRINET and CONSTANCES, which include for each over 200.000 individuals belongingto the French general population. He has been recently appointed as the Section Editor for Epidemiology of the Journal of the European Academy of Dermatology and Venereology. He is also the Co-Director of the Global Vitiligo Atlas (GLOVA) created under the auspices of the International League of Dermatological Societies (ILDS), a group of clinicians and researchers aiming on harmonizing standardized global data on prevalence and comorbidities in vitiligo as well as accumulating evidence of the impact and burden of vitiligo on patient’s life.